Mariendistelfrüchte Bombastus-Werke

Milk Thistle Fruit, the active ingredient in Mariendistelfrüchte Bombastus-Werke, is a herbal presented as an oral herbal preparation for oral use. It is traditionally used to support liver health and is offered without a prescription.

GNH USA supplies Mariendistelfrüchte Bombastus-Werke as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milk Thistle Fruit is employed to support hepatic function and related conditions. - Mild liver dysfunction: helps maintain normal liver enzyme levels. - Non‑alcoholic fatty liver disease: may assist in reducing hepatic fat accumulation. - Drug‑induced hepatotoxicity: provides antioxidant protection during exposure to hepatotoxic agents.

Adverse reactions to Milk Thistle Fruit are generally uncommon but may occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Mild allergic reactions: skin rash or itching. - Headache: transient mild headache reported in some users.

Serious or Rare Side Effects: - Anaphylaxis: rare severe allergic response requiring immediate medical attention. - Elevated liver enzymes: unexpected increase in hepatic transaminases. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Milk Thistle Fruit should be used with caution in certain situations. - Pregnancy: safety not established; avoid unless prescribed. - Breastfeeding: insufficient data; consider risk versus benefit. - Concomitant hepatotoxic drugs: monitor liver function closely. - Underlying liver disease: use under medical supervision. - Known hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Milk Thistle Fruit may affect the activity of several medicines.

Major Interactions (Avoid): - Warfarin: potential increase in bleeding risk. - Anticonvulsants (e.g., phenytoin): may reduce seizure control. - Chemotherapy agents: possible interference with drug metabolism.

Moderate Interactions (Monitor Closely): - Statins: additive risk of liver enzyme elevation. - Diabetes medications: may alter glucose control. - Other hepatoprotective herbs: risk of cumulative dosing effects.